Supplemental Methods. Detailed methods on DNA preparation, hybridization, exome sequencing, variant calling, use of ethnicity-informative variation, quality control, and capture region matching. (PDF 233 kb
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Supplementary Methods: Description of methods for pooled variant calling, gene-level tests for rare ...
BMC Med Gen Submission - Jones 2019_Novel sarcoma risk genes in cancer cluster families_Supp Materia...
Table S2. InterVar classification of ACMG SF v2.0 cancer genes after expert review. (XLSX 30 kb
Figure S1. Bioinformatics workflow for detecting pathogenic variants. Variants are first binned into...
Additional file 1: Table S1. Cancer Site Coding Following SEER and WHO Guidelines. Table S2. Unique ...
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
Table S1. contains the list of the genes used in the study, as well as indicators for which pathway ...
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Sample preparation, sequencing, analysis and variant validation workflow. (TIF 2207 kb
Table S2. Filtered variants detected in three or more patients. Chromosome, start, end - genome coor...
List with all genes (exome-wide) presenting a PDAV in at least two BC patients and the number of con...
Additional file 2: Figure S1. Genetic Ancestry in the Kaiser Permanente Research Bank and UK Biobank...
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Supplementary Methods: Description of methods for pooled variant calling, gene-level tests for rare ...
BMC Med Gen Submission - Jones 2019_Novel sarcoma risk genes in cancer cluster families_Supp Materia...
Table S2. InterVar classification of ACMG SF v2.0 cancer genes after expert review. (XLSX 30 kb
Figure S1. Bioinformatics workflow for detecting pathogenic variants. Variants are first binned into...
Additional file 1: Table S1. Cancer Site Coding Following SEER and WHO Guidelines. Table S2. Unique ...
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
Table S1. contains the list of the genes used in the study, as well as indicators for which pathway ...
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Sample preparation, sequencing, analysis and variant validation workflow. (TIF 2207 kb
Table S2. Filtered variants detected in three or more patients. Chromosome, start, end - genome coor...
List with all genes (exome-wide) presenting a PDAV in at least two BC patients and the number of con...
Additional file 2: Figure S1. Genetic Ancestry in the Kaiser Permanente Research Bank and UK Biobank...
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Supplementary Methods: Description of methods for pooled variant calling, gene-level tests for rare ...
BMC Med Gen Submission - Jones 2019_Novel sarcoma risk genes in cancer cluster families_Supp Materia...